CA2478415A1 - A multifunctional complex for targeting specific phagocytosis of a target agent - Google Patents

A multifunctional complex for targeting specific phagocytosis of a target agent Download PDF

Info

Publication number
CA2478415A1
CA2478415A1 CA002478415A CA2478415A CA2478415A1 CA 2478415 A1 CA2478415 A1 CA 2478415A1 CA 002478415 A CA002478415 A CA 002478415A CA 2478415 A CA2478415 A CA 2478415A CA 2478415 A1 CA2478415 A1 CA 2478415A1
Authority
CA
Canada
Prior art keywords
component
targeting
complex
agent
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002478415A
Other languages
English (en)
French (fr)
Inventor
Jacob Pitcovski
Ely Morag
Yosef Pinchasov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YAMIT BIOTECHNOLOGIES Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2478415A1 publication Critical patent/CA2478415A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267Gram-positive bacteria
    • C07K16/1275Streptococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Gram-negative bacteria
    • C07K16/1228Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • C07K16/1232Escherichia (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA002478415A 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent Abandoned CA2478415A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL148598A IL148598A (en) 2002-03-10 2002-03-10 Multifunctional complex for targeting specific phagocytosis of a target agent and a composition comprising it
IL148598 2002-03-10
PCT/IL2003/000196 WO2003076471A2 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent

Publications (1)

Publication Number Publication Date
CA2478415A1 true CA2478415A1 (en) 2003-09-18

Family

ID=27799844

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002478415A Abandoned CA2478415A1 (en) 2002-03-10 2003-03-10 A multifunctional complex for targeting specific phagocytosis of a target agent

Country Status (8)

Country Link
US (1) US20040258664A1 (https=)
EP (1) EP1485414A2 (https=)
JP (1) JP2006504619A (https=)
AU (1) AU2003212633A1 (https=)
CA (1) CA2478415A1 (https=)
IL (1) IL148598A (https=)
MX (1) MXPA04008847A (https=)
WO (1) WO2003076471A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2339436A1 (fr) * 2001-03-15 2002-09-15 Josee Harel Production d'anticorps contre les facteurs de virulence associes aux souches d'escherichia coli aeec, et leur utilisation
KR20110097960A (ko) * 2008-12-19 2011-08-31 가부시끼가이샤 사이와이 메딕스 단백질 가교 고정 시약으로 고정시킨 미생물을 항원으로서 이용하는 망라적 항표면 항체 제조 방법
JP5439127B2 (ja) * 2009-11-13 2014-03-12 株式会社さいわいメディカル 乾癬又はアトピー性皮膚炎治療剤
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
CN103323585B (zh) * 2013-06-06 2015-07-22 广东海大畜牧兽医研究院有限公司 一种检测鱼类无乳链球菌IgM抗体的ELISA试剂盒及其制备方法
US9791440B2 (en) 2013-07-15 2017-10-17 President And Fellows Of Harvard College Assays for antimicrobial activity and applications thereof
WO2015093546A1 (ja) 2013-12-18 2015-06-25 旭化成株式会社 乳汁中のストレプトコッカス属の菌を検出する方法
WO2015109012A1 (en) 2014-01-14 2015-07-23 Integrated Biotherapeutics, Inc. Targeting immunological functions to the site of bacterial infections using cell wall targeting domains of bacteriolysins
CN108623680A (zh) * 2017-03-17 2018-10-09 蒙永祥 复合抗体提取物及其制备方法和应用
EP4480961A1 (en) 2023-06-23 2024-12-25 Consejo Superior De Investigaciones Científicas Pathogen trapping systems and related aquacultural uses
EP4570822A1 (en) * 2023-12-15 2025-06-18 Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. Immunizing and/or medical preparation for use in preventing and/or treating inflammatory conditions of cow udder

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01168246A (ja) * 1987-12-24 1989-07-03 Taiyo Kagaku Co Ltd 特異的鶏卵抗体を配合してなる養殖魚用飼料
EP0396116B1 (en) * 1989-05-02 1997-02-05 Abbott Laboratories Covalent attachment of specific binding members to a solid phase
US6030805A (en) * 1989-05-04 2000-02-29 Normark; Staffan Fibronectin binding protein as well as its preparation
JPH0356426A (ja) * 1989-07-24 1991-03-12 Gifu Meneki Kenkyusho:Kk ウシ乳房炎予防および治療用抗体含有材料
US5064645A (en) * 1990-07-27 1991-11-12 Pisciconsult Developpement Inc. Hyperimmune composition for passive immunization of fishes against furunculosis caused by Aeromonas salmonicida
GB9112310D0 (en) * 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
US5585098A (en) * 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
US5700465A (en) * 1994-01-05 1997-12-23 American Cyanamid Company Bovine serum and bovine IgG as preventives and therapeutives for bovine mastitis
US6143559A (en) * 1996-11-18 2000-11-07 Arch Development Corporation Methods for the production of chicken monoclonal antibodies
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
US20050196755A1 (en) * 2000-11-17 2005-09-08 Maurice Zauderer In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
DE10123505A1 (de) * 2001-05-15 2002-11-28 Wolfgang Bergter Immunkonjugate aus Eidotter-Antikörpern (lgY), deren Konfektionierung und Anwendung in Diagnostik und Therapie

Also Published As

Publication number Publication date
IL148598A (en) 2008-04-13
WO2003076471A3 (en) 2004-01-08
WO2003076471A2 (en) 2003-09-18
JP2006504619A (ja) 2006-02-09
IL148598A0 (en) 2002-09-12
EP1485414A2 (en) 2004-12-15
US20040258664A1 (en) 2004-12-23
AU2003212633A1 (en) 2003-09-22
MXPA04008847A (es) 2005-06-17

Similar Documents

Publication Publication Date Title
Kovacs-Nolan et al. Avian egg antibodies: basic and potential applications
US5585098A (en) Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
AU729502B2 (en) Oral administration of chicken yolk antibodies to treat disease
JP2548115B2 (ja) トリの抗体を用いた哺乳動物の受動免疫化
CA2260007C (en) Method for treating gastrointestinal damage
JP2008179634A (ja) グラム陽性細菌のリポタイコ酸に特異的なオプソニン性モノクローナルおよびキメラ抗体
US20020044942A1 (en) Transfer factor composition and process for producing same
US20040258664A1 (en) Multifunctional complex for targeting specific phagocytosis of a target agent
JP2002501526A (ja) 乳汁における免疫グロブリンaの生成方法
KR102047784B1 (ko) 송아지 소화기성 질병의 예방 또는 치료용 난황항체 제조방법, 이에 의해 제조된 난황항체 및 이의 용도
EP2500034A1 (en) Therapeutic agent for psoriasis or atopic dermatitis
Akita et al. Neutralization of enterotoxigenic escherichia coli heat‐labile toxin by chicken egg yolk immunoglobulin Y and its antigen‐binding fragments
KR20170007853A (ko) 항체 가이드된 백신 및 신속한 성숙 면역 반응을 생성하기 위한 사용 방법
JP2005514053A6 (ja) グラム陽性細菌のリポタイコ酸に特異的なオプソニン性モノクローナルおよびキメラ抗体
Daley et al. Lysostaphin: immunogenicity of locally administered recombinant protein used in mastitis therapy
Rahman Egg yolk antibody-IgY
US20070264264A1 (en) Method and composition for conferring immunity in mammals
Kaplin et al. IgY-Technologies. Birds Yolk Antibodies
Chitra Egg yolk antibodies (IgY) and its therapeutic uses for human and animal health-A review
Watson Synergism between antibody and neutrophils in the ruminant mammary gland
KR100280333B1 (ko) 대장균k987p필리항원에대한난황항체의분리방법
AU673589B2 (en) Therapeutic formulation and method
JP2014019693A (ja) 経口免疫ワクチン、経口免疫ワクチン用アジュバント、並びに動物に対する経口免疫ワクチンの接種方法
KR20010037612A (ko) 돼지 대장균 설사증 예방 및 치료용 특이항체를 포함한 난황건조분말을 이용한 사료첨가제
JPH05306238A (ja) 特異的抗体及びカイコ感染症防除組成物

Legal Events

Date Code Title Description
FZDE Discontinued